Number of Participants With Unacceptable Toxicity [clinicaltrials_resource:NCT00667342/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Number of Participants With Unacceptable Toxicity [clinicaltrials_resource:NCT00667342/outcome/1]
Bio2RDF identifier
NCT00667342/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00667342/outcome/1
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
All Stratum A participants wer ...... the 12 Stratum C participants.
Due to slow accrual, the trial ...... ng this feasibility objective.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
After 6 cycles of chemotherapy, up to 1 year after the start of therapy
After all patients have completed therapy, up to 1 year after last patient is enrolled
After all patients have completed therapy, up to 3 years after last patient is enrolled
After all patients have completed therapy, up to 4 years after last patient is enrolled
type [clinicaltrials_vocabulary:type]
alternate
Number of Participants With Unacceptable Toxicity
@en
identifier
clinicaltrials_resource:NCT00667342/outcome/1
title
Objective: To study the feasib ...... itoring unacceptable toxicity.
@en
type
label
Number of Participants With Un ...... esource:NCT00667342/outcome/1]
@en